Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Collegium Pharmaceutical ( (COLL) ) has provided an update.
Collegium Pharmaceutical announced the appointment of David Dieter as Executive Vice President and General Counsel, effective March 17, 2025. Mr. Dieter brings extensive legal experience from his previous roles, including serving as Vice President, Legal at Horizon Therapeutics USA, Inc., and holding leadership positions at Takeda. His appointment is expected to strengthen Collegium’s legal and business development capabilities.
More about Collegium Pharmaceutical
YTD Price Performance: 2.90%
Average Trading Volume: 407,550
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $927.6M
Learn more about COLL stock on TipRanks’ Stock Analysis page.